Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
about
Analysis of cDNAs of the proto-oncogene c-src: heterogeneity in 5' exons and possible mechanism for the genesis of the 3' end of v-src.Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.The first exon of the c-myc proto-oncogene contains a novel positive control element.Rapid and reversible changes in nucleosome structure accompany the activation, repression, and superinduction of murine fibroblast protooncogenes c-fos and c-myc.Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements.Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.The relationship between mRNA stability and length in Saccharomyces cerevisiaeAn estrogen-dependent polysomal protein binds to the 5' untranslated region of the chicken vitellogenin mRNA.Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoterOver-expression of the c-myc proto-oncogene in colorectal carcinoma.RNAs in Epstein-Barr virions control early steps of infection.Oestrogen receptor protein and mRNA in adenocarcinoma of the uterine cervix.Analysis of the 3' flanking region of the human c-myc gene in lymphomas with the t(8;22) and t(2;8) chromosomal translocationsIdentification of sequences in c-myc mRNA that regulate its steady-state levels.Exon 2-mediated c-myc mRNA decay in vivo is independent of its translationEstradiol and estrogen receptor-dependent stabilization of a minivitellogenin mRNA lacking 5,100 nucleotides of coding sequence.A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells.Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component.6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target.Haploid-specific transcription of protamine-myc and protamine-T-antigen fusion genes in transgenic miceDifferential stability of c-myc mRNAS in a cell-free system.Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA.Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement.Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas.Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas.Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences.RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences.Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders.Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression.Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA.Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.Alternate structures and stabilities of c-myc RNA in a bursal lymphoma cell line.Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation.Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells.Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation.Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cellsEpstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
P2860
Q33264705-8EF31CCB-2FEF-454E-8FE9-BA21B47376D7Q33797347-221DBC92-533D-4A58-B384-340FB186BA64Q33881231-ED0E9335-060A-4A47-88E8-8AEFF283A7E3Q34333538-4BA9A0B0-88B8-47E2-8197-1979DDB183F7Q34364003-40FBBB29-1A38-4D7D-BF5A-A046636D7CDBQ34641385-F720DF2C-686D-4ED3-892D-6C4C14FE03B9Q34992987-4860B62E-B8D6-4EDD-83F4-5C831EFFD906Q35055614-250ED18A-1B51-4B27-9119-888771767807Q35804246-29C5DC7C-0B13-4CB5-921A-AFCF8AB6E269Q35939969-F319F70D-F13E-4BF6-906F-2DE2F136DA9DQ35977137-71B4113D-DC55-4CDC-A450-4DA205F4B965Q35991530-B4101F50-F10E-4EC8-8AAF-0045D12FB384Q35994625-D7303C06-A0E2-4591-A05A-804359181AD3Q36099554-AC5139A2-A5EF-4E92-89A9-2901118D4A79Q36560690-2847390C-45B2-46B1-A706-98638B27CCFAQ36562367-5C297D5E-9B6D-420F-968B-647E02020C8CQ36714486-1B2A2CD3-7B79-4B44-B088-B4E11127D7CCQ36733602-533624FC-57DA-41BE-8463-774970033EF5Q36777102-02C4A4D9-E333-4206-98B6-7891142EF3D4Q36781332-61A870DB-CED1-4858-974D-1404D93724E0Q36787144-AC0E3A21-9DBD-4D5C-8AA6-248454674517Q36791935-2E1F4CDA-50B9-4812-A83F-384F7C05C46DQ36792857-907E7787-DFDD-4B75-BA12-DB184A9C4F19Q36835881-19E0A753-82C8-4294-A41E-54B79FCCCAB7Q36897376-B942303E-D2D7-4CB9-BC7E-64E24E39A1F1Q36897540-B4953A8C-8AA2-4DAF-ABD3-BEAC46A341C4Q36918435-1A500F9E-FCA4-44FE-8CBE-AC369823AB35Q36925736-1C747FF0-7BD1-4420-97CD-ACF77097B645Q37385250-7D58B014-23CC-4C86-8409-7E1F22CDC03CQ37401592-30BAAA6E-8B65-4532-B46B-4C57467F9A0DQ38125066-1CE61090-157E-48E4-BD02-8978FFBE6A95Q40419300-B74A9063-F3CC-4CDB-8ACA-4B2F56991CBFQ40510170-623B0943-121B-4C11-91B8-3D1B9148AEF6Q40514722-00492BE6-52E1-4CFD-B605-3ADB79BB5F61Q40557556-FD5EB952-6D73-4D35-B95B-34EED6F3FEBCQ40567159-B5FE74FA-729C-4692-8E20-142B708C39CBQ40569415-23FC0385-F39E-4274-A301-2D3EBC70307DQ40818267-D4B434D8-2AED-41C6-A0F0-D2C19AE17472Q40874071-0D245793-8CE8-47CE-BE7B-0069C65277FDQ41063703-9625FB3B-82CF-4DF7-B800-CC94B539CFD7
P2860
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@ast
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@en
type
label
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@ast
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@en
prefLabel
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@ast
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@en
P2093
P2860
P4510
P1433
P1476
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives
@en
P2093
Blanchard JM
Bornkamm GW
Henglein B
Piechaczyk M
P2860
P304
P356
10.1002/J.1460-2075.1985.TB04140.X
P407
P577
1985-12-01T00:00:00Z